Literature DB >> 19362302

A differential cytokine expression profile is induced by highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone in a pre- and postovulatory mouse follicle culture model.

Rebecca Foster1, Ingrid Segers, David Smart, Tom Adriaenssens, Johan Smitz, Joan-Carles Arce, Marc Princivalle.   

Abstract

OBJECTIVE: To compare the differential effects of highly purified (HP) hMG or recombinant FSH (rFSH) on cytokine expression before and after ovulation in an in vitro mouse ovarian follicle model.
DESIGN: A prospective laboratory in vitro study.
SETTING: A university-based reproductive biology laboratory. MATERIAL(S): Mechanically isolated mouse preantral follicles from 14-day-old prepubertal mouse ovaries (F1 hybrids: C57BL/6JxCBA/ca). INTERVENTION(S): Randomly distributed mouse early preantral follicles were exposed to two hyperstimulation conditions with either HP-hMG or rFSH. An ovulatory stimulus was given using hCG/epidermal growth factor. Conditioned media from the two culture conditions were collected on the days before and after in vitro ovulation. Conditioned media were compared for their relative cytokine profile content as measured by a cytokine antibody array analysis. MAIN OUTCOME MEASURE(S): Relative concentrations of 62 cytokines in conditioned media before and after ovulation. RESULT(S): Statistically significant increase in the production of a number of cytokines was found after HP-hMG stimulation compared with rFSH: 14 and 24 pre- and post-rhCG, respectively. Cytokines with the largest significant difference (more than 5 times) before and after ovulation included thymus-expressed cytokine (TECK), sTNFRI, and SDF-1alpha. The cytokines that are most strongly related to oocyte and embryo quality and implantation and that have been related to oocyte yield and maturation were significantly higher with HP-hMG. CONCLUSION(S): The significant differences in follicular cytokine production induced by HP-HMG and rFSH before and after in vitro ovulation might explain the difference in treatment outcome. Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19362302     DOI: 10.1016/j.fertnstert.2009.01.136

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Synergy of Paracrine Signaling During Early-Stage Mouse Ovarian Follicle Development In Vitro.

Authors:  Hong Zhou; Joseph T Decker; Melissa M Lemke; Claire E Tomaszweski; Lonnie D Shea; Kelly B Arnold; Ariella Shikanov
Journal:  Cell Mol Bioeng       Date:  2018-08-09       Impact factor: 2.321

Review 2.  Ovulation: Parallels With Inflammatory Processes.

Authors:  Diane M Duffy; CheMyong Ko; Misung Jo; Mats Brannstrom; Thomas E Curry
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

3.  Pituitary-ovary-spleen axis in ovulation.

Authors:  Oliver R Oakley; Michele L Frazer; CheMyong Ko
Journal:  Trends Endocrinol Metab       Date:  2011-05-18       Impact factor: 12.015

4.  A macrophage and theca cell-enriched stromal cell population influences growth and survival of immature murine follicles in vitro.

Authors:  Candace M Tingen; Sarah E Kiesewetter; Jennifer Jozefik; Cristina Thomas; David Tagler; Lonnie Shea; Teresa K Woodruff
Journal:  Reproduction       Date:  2011-03-09       Impact factor: 3.906

5.  Redox Biology of Human Cumulus Cells: Basic Concepts, Impact on Oocyte Quality, and Potential Clinical Use.

Authors:  Lucia von Mengden; Fabio Klamt; Johan Smitz
Journal:  Antioxid Redox Signal       Date:  2020-03-10       Impact factor: 8.401

6.  Live-birth rates after HP-hMG stimulation in the long GnRH agonist protocol: association with mid-follicular hCG and progesterone concentrations, but not with LH concentrations.

Authors:  Joan-Carles Arce; Johan Smitz
Journal:  Gynecol Endocrinol       Date:  2012-07-19       Impact factor: 2.260

7.  Comparison of the tumor cell secretome and patient sera for an accurate serum-based diagnosis of pancreatic ductal adenocarcinoma.

Authors:  Shakhawan Mustafa; Longqiang Pan; Aseel Marzoq; Malak Fawaz; Laureen Sander; Felix Rückert; Andrea Schrenk; Christina Hartl; Rico Uhler; Adem Yildirim; Oliver Strobel; Thilo Hackert; Nathalia Giese; Markus W Büchler; Jörg D Hoheisel; Mohamed Saiel Saeed Alhamdani
Journal:  Oncotarget       Date:  2017-02-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.